We are live on ! Find out more
NGNE icon

Neurogene
NGNE

22 hedge funds and large institutions have $31.2M invested in Neurogene in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

13% more capital invested

Capital invested by funds: $27.6M → $31.2M (+$3.62M)

0% more funds holding

Funds holding: 22 → 22 (0)

38% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 8

Holders
22
Holders Change
–
Holders Change %
0%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
8
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
+$360K
2
Deutsche Bank
Deutsche Bank
Germany
+$358K
3
RA
Royce & Associates
New York
+$333K
4
BC
Broadfin Capital
New York
+$151K
5
SIM
Spark Investment Management
New York
+$81.9K

Top Sellers

Rank Fund Capital Flow
1
DCM
Driehaus Capital Management
Illinois
-$643K
2
Franklin Resources
Franklin Resources
California
-$161K
3
HCMT
Highland Capital Management (Texas)
Texas
-$137K
4
Jane Street
Jane Street
New York
-$133K
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$26.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$9.08M -$10.7K -75 -0.1%
Franklin Resources
2
Franklin Resources
California
$4.42M -$161K -1,128 -4%
BC
3
Broadfin Capital
New York
$3.99M +$151K +1,063 +4%
VAM
4
Visium Asset Management
New York
$2.62M +$360K +2,525 +17%
CAM
5
Cormorant Asset Management
Massachusetts
$2.25M – – –
DCM
6
Driehaus Capital Management
Illinois
$1.87M -$643K -4,512 -27%
HCMT
7
Highland Capital Management (Texas)
Texas
$1.18M -$137K -962 -11%
RA
8
Royce & Associates
New York
$978K +$333K +2,336 +56%
PA
9
Perceptive Advisors
New York
$975K – – –
PI
10
Putnam Investments
Massachusetts
$864K – – –
BA
11
BlackRock Advisors
Delaware
$854K -$2.85K -20 -0.4%
Alyeska Investment Group
12
Alyeska Investment Group
Illinois
$764K -$26.8K -188 -4%
Deutsche Bank
13
Deutsche Bank
Germany
$517K +$358K +2,511 +266%
BG
14
BlackRock Group
United Kingdom
$366K – – –
BlackRock
15
BlackRock
New York
$181K – – –
Geode Capital Management
16
Geode Capital Management
Massachusetts
$120K – – –
SCM
17
Sterling Capital Management
North Carolina
$97K -$12.2K -86 -12%
SIM
18
Spark Investment Management
New York
$86K +$81.9K +575 New
BIT
19
BlackRock Institutional Trust
California
$20K – – –
Citigroup
20
Citigroup
New York
$11K +$7.12K +50 +200%
TRCT
21
Tower Research Capital (TRC)
New York
$8K -$6.98K -49 -49%
Jane Street
22
Jane Street
New York
– -$133K -1,000 Closed
Morgan Stanley
23
Morgan Stanley
New York
– +$142 +1 New

NGNE Hedge Fund Activity: Q4 2014 in Review

22 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q4 2014, worth a combined $31.2M — up 13% from $27.6M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new NGNE positions and 1 closed out — a net gain of 1 holder — while 5 added to existing stakes and 8 trimmed.

The largest buyer was Visium Asset Management, adding an estimated $360K. The largest seller was Driehaus Capital Management, cutting an estimated $643K.

  • 22 institutional investors held Neurogene (NGNE) as of Q4 2014, unchanged from Q3 2014.
  • Funds reported $31.2M of Neurogene stock for Q4 2014, up 13% quarter-over-quarter.
  • 2 funds opened new Neurogene positions in Q4 2014 and 1 closed out, a net change of +1 holder.
  • The largest Neurogene buyer in Q4 2014 was Visium Asset Management, an estimated $360K added.
  • The largest Neurogene seller in Q4 2014 was Driehaus Capital Management, an estimated $643K sold.

Based on aggregated 13F filings for Q4 2014.